Dr. Imran Afridi, MD

Dr. Afridi practices at Methodist Southwest Medical Center in Dallas, Texas, part of Methodist Hospitals of Dallas.

Dr. Afridi's NPI, 1861459927, was assigned on May 1, 2006. Dr. Afridi graduated from Dow University of Health Sciences in 1988. Dr. Afridi holds Texas license J-2474.

Dr. Afridi's primary practice is Methodist Southwest Medical Center, at 3500 W Wheatland Road, Dallas, TX 75237 in Dallas County. The practice phone is (214) 947-7777.

Dr. Afridi's primary practice is Methodist Southwest Medical Center in Dallas, Texas, part of Methodist Hospitals of Dallas. Dr. Afridi is also affiliated with Methodist Dallas Medical Center. The medical group on file is Billings Clinic. Dmand AI also links Dr. Afridi to 3 more hospitals, 3 group practices and clinics, 3 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Afridi practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Afridi's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Afridi is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Afridi's licenses on file in 4 states: Texas, Montana, Michigan and Ohio.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic embolism thrombosis, chronic hypertension, chronic skin ulcer and coronary artery disease among the conditions Dr. Afridi treats.

CMS data shows 1,034 Medicare services from Dr. Afridi across 15 procedure codes in 2024, for 272 Medicare patients. Medicare paid $59,635 for them.

CMS counts 272 Medicare patients who saw Dr. Afridi in 2024. The largest group is 65 to 74, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Afridi's median patient age at 70, with 51% women.

In 2024, Dr. Afridi wrote 3,082 Medicare Part D claims for 535 patients. 82% of them were for generic drugs. CMS names the drug for 2,923 of them, across 36 drugs with 11 or more claims each, at $580,625 in total drug cost. In 2023, CMS named 3,015 claims across 35 drugs.

Dr. Afridi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Afridi. The most frequent topics are Echocardiography, Ventricular Dysfunction, Left and Dobutamine. Dr. Afridi has published most often in Circulation. Dr. Afridi's most frequent co-authors are Paul A. Grayburn, MD, William Zoghbi, MD and Ali M. Kizilbash, MD.

CMS Open Payments shows 213 general payments to Dr. Afridi from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $515. It also lists 1 research payment totaling $6,224 in 2025.

Dmand AI lists 3 awards for Dr. Afridi, most recently CMS Stage 1 EHR in 2013.

Dr. Afridi graduated from Dow University of Health Sciences in 1988. Dr. Afridi is a member of ACC.

Dr. Afridi is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.